Regeneron Pharmaceuticals, Inc. (REGN) Deep Dive Video

Summary

Regeneron is a science-led biotech compounding machine approaching a 2026 earnings step-change—if it can successfully defend Eylea while biosimilars and Vabysmo close in.

View REGN stock page · Read the REGN research report

Loading the video player…